DULOXETINE HYDROCHLORIDE | N219131 | ALMATICA PHARMA LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Kathy Lynn Bramel Easterday FDA-2026-P-1831 · 3 docket documents Kathy Lynn Bramel Easterday filed this petition under sections 502, 505, 701, and related provisions of the Federal Food, Drug, and Cosmetic Act requesting that the FDA Commissioner require NDA holders and generic manufacturers of Cymbalta (duloxetine hydrochloride) to develop and make available sta | 505(q) | 2026-02-19 | Open | Kathy Lynn Bramel Easterday |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$5.66
per ea
Lowest NADAC/Unit
$5.65
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 52427079130DULOXETINE HCL DR 120 MG CAP | $5.66 | EA | Generic | — | 2026-10-21 |
| 52427091330DULOXETINE HCL DR 90 MG CAP | $5.65 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 12721817 | Jan 13, 2046 | — | — | Yes | — | — |